Literature DB >> 26581003

HABP2 Mutation and Nonmedullary Thyroid Cancer.

E Yihui Zhou, Zhimiao Lin, Yong Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26581003     DOI： 10.1056/NEJMc1511631

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  G534E Variant in HABP2 and Nonmedullary Thyroid Cancer.

Authors:  Macarena Ruiz-Ferrer; Raquel M Fernández; Elena Navarro; Guillermo Antiñolo; Salud Borrego
Journal:  Thyroid       Date:  2016-07       Impact factor: 6.568

2.  Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.

Authors:  Chen-Tian Shen; Guo-Qiang Zhang; Zhong-Ling Qiu; Hong-Jun Song; Zhen-Kui Sun; Quan-Yong Luo
Journal:  Endocrine       Date:  2019-03-02       Impact factor: 3.633

3.  HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.

Authors:  Alexia L Weeks; Scott G Wilson; Lynley Ward; Jack Goldblatt; Jennie Hui; John P Walsh
Journal:  BMC Med Genet       Date:  2016-08-17       Impact factor: 2.103

4.  The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population.

Authors:  Artur Kowalik; Danuta Gąsior-Perczak; Martyna Gromek; Monika Siołek; Agnieszka Walczyk; Iwona Pałyga; Małgorzata Chłopek; Janusz Kopczyński; Ryszard Mężyk; Aldona Kowalska; Stanisław Góźdź
Journal:  Oncotarget       Date:  2017-04-06

5.  HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.

Authors:  Maisa Pinheiro; Sandra Aparecida Drigo; Renata Tonhosolo; Sonia C S Andrade; Fabio Albuquerque Marchi; Igor Jurisica; Luiz Paulo Kowalski; Maria Isabel Achatz; Silvia Regina Rogatto
Journal:  Oncotarget       Date:  2017-06-20

Review 6.  Genetic susceptibility to hereditary non-medullary thyroid cancer.

Authors:  Tina Kamani; Parsa Charkhchi; Afshan Zahedi; Mohammad R Akbari
Journal:  Hered Cancer Clin Pract       Date:  2022-03-07       Impact factor: 2.857

7.  The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in Hispanics.

Authors:  Mabel E Bohórquez; Ana P Estrada; Jacob Stultz; Ruta Sahasrabudhe; John Williamson; Paul Lott; Carlos S Duque; Jorge Donado; Gilbert Mateus; Fernando Bolaños; Alejandro Vélez; Magdalena Echeverry; Luis G Carvajal-Carmona
Journal:  Endocr Connect       Date:  2016-04-20       Impact factor: 3.335

8.  Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer.

Authors:  Glenn S Gerhard; Darrin V Bann; James Broach; David Goldenberg
Journal:  NPJ Genom Med       Date:  2017-03-28       Impact factor: 8.617
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.